aTyr Pharma (LIFE) PT Raised to $12 at Oppenheimer with COVID Data Expected by Year End
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh raised the price target on aTyr Pharma (NASDAQ: LIFE) to $12.00 (from $8.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
